Search Results 451-460 of 12192 for SC
... SC, Rasmussen G, Tina E, Soderquist B, Kallman J, Stralin K, Lange AL, Sunden-Cullberg JS, Magnuson AM, Hultgren OH, Davies G, Pillai S, Mills G, Aubrey R ...
The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...
... SC, Buckles S, Bumgardner M, Gallagher C, Fee-Schroeder K, Nicholas NR, Powers ML, Ragab AK, Richardson DM, Stai A, Wilson J, Pacyna JE, Olson JE, Sutton EJ ...
The purpose of this study is to evaluate the effectiveness of depemokimab 200 mg subcutaneous (SC) given every 6 months versus placebo in participants with ...
... SC) in combination with carfilzomib and dexamethasone (Kd) with the efficacy of Kd in participants with relapsed refractory multiple myeloma who were ...
Richard Drake, Ph.D. Medical University of South Carolina. James Fagin, M.D.. Memorial Sloan Kettering Cancer Center. Bryan Haugen, M.D..
... SC, Trpkov K, Williamson SR, Sangoi AR, Mohanty S, McKenney JK, Gupta S ... SC, Sharma V, Sethi S, Herrera-Hernandez L, Jimenez RE, Cheville JC ...
Symptoms include cramping, belly pain, bloating, gas, and diarrhea or constipation, or both. IBS is an ongoing condition that needs long-term management.
BS South Carolina State University. src="/-/media/kcms/gbs/research/images/. Clinical Studies. Learn about clinical trials that address specific scientific ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.